Analysts See $-0.52 EPS for Invuity, Inc. (IVTY)

April 19, 2018 - By Richard Conner

Invuity, Inc. (NASDAQ:IVTY) Logo

Analysts expect Invuity, Inc. (NASDAQ:IVTY) to report $-0.52 EPS on April, 25.They anticipate $0.12 EPS change or 18.75 % from last quarter’s $-0.64 EPS. After having $-0.43 EPS previously, Invuity, Inc.’s analysts see 20.93 % EPS growth. The stock decreased 3.90% or $0.15 during the last trading session, reaching $3.7. About 277,222 shares traded or 9.97% up from the average. Invuity, Inc. (NASDAQ:IVTY) has declined 54.52% since April 19, 2017 and is downtrending. It has underperformed by 66.07% the S&P500.

Invuity, Inc., a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company has market cap of $86.50 million. The firm integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges. It currently has negative earnings. It offers various illuminated surgical devices, including Eikon LT Illuminated and Eikon illuminated retractor systems for breast oncology/oncoplastic/general/orthopedics surgeries; Saber Yankauer, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general surgeries; and Saber Frazier, a handheld illuminator for spine/orthopedic/neurosurgery surgeries.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: